PHARMACOTHERAPY OF SCHIZOPHRENIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AKHOUNDZADEH SH.; AFKHAM KH.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Psychiatry Year:2006 | Volume:1 | Issue:2 Page(s): 46-53

Download Full-Text

View:

286

Download:

131

Cites:

Information Journal Paper

Title

PHARMACOTHERAPY OF SCHIZOPHRENIA

Author(s)

AKHOUNDZADEH SH. | AFKHAM KH. | Issue Writer Certificate

Keywords

ANTIPSYCHOTIC AGENTS

DOPAMINE

DRUG THERAPY

ETIOLOGY

SCHIZOPHRENIA

SEROTONINE

Abstract

Traditionally, SCHIZOPHRENIA was considered to be a severe psychiatric disorder, with a chronic course and an unfavorable outcome. Throughout history, there has been incidence of SCHIZOPHRENIA, roughly one percent of the population, consistently, in every culture. It is generally acknowledged that SCHIZOPHRENIA has multifactorial ETIOLOGY, with multiple susceptibility genes interacting with environmental insults to yield a range of phenotypes in the SCHIZOPHRENIA spectrum. The discovery of antipsychotics in the 1950s revolutionized the treatment of SCHIZOPHRENIA and focused on the positive symptoms. By the 1960s, however, it became evident that the reduction in positive symptoms did not lead to recovery from SCHIZOPHRENIA and did not significantly improve the functional outcome. The advent of the novel antipsychotics during the last 15 years represents a significant improvement over the effectiveness of conventional antipsychotics. These agents are, however, not a magic bullet and bear their own side effects, such as weight gain, diabetes, hyperprolactinemia, and QTc prolongation. Nevertheless, at this point, they seem to be more effective and safer than the conventional antipsychotics. Moreover, advances in the treatment of SCHIZOPHRENIA have been and continue to be urgently needed.

Cites

No record.

References

No record.

Cite

APA: Copy

AKHOUNDZADEH, SH., & AFKHAM, KH.. (2006). PHARMACOTHERAPY OF SCHIZOPHRENIA. IRANIAN JOURNAL OF PSYCHIATRY, 1(2), 46-53. SID. https://sid.ir/paper/302203/en

Vancouver: Copy

AKHOUNDZADEH SH., AFKHAM KH.. PHARMACOTHERAPY OF SCHIZOPHRENIA. IRANIAN JOURNAL OF PSYCHIATRY[Internet]. 2006;1(2):46-53. Available from: https://sid.ir/paper/302203/en

IEEE: Copy

SH. AKHOUNDZADEH, and KH. AFKHAM, “PHARMACOTHERAPY OF SCHIZOPHRENIA,” IRANIAN JOURNAL OF PSYCHIATRY, vol. 1, no. 2, pp. 46–53, 2006, [Online]. Available: https://sid.ir/paper/302203/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops